Podcast interview with Dr. Elvira Müller. EU joint HTA – decided, but how will it be executed and how should companies prepare
In Europe, there are at least as many reimbursement assessment processes in place as European…
Certara2023 年 2 月 7 日
FDA awards new grants to support developing & assessing complex generic drugs
Certara’s Simcyp physiologically-based pharmacokinetic (PBPK) Simulator is being used to verify and expand biosimulation models…
Certara2023 年 2 月 7 日
Artificial Intelligence: What is it & how can it accelerate rare disease drug development?
Large & complex information streams present opportunities for the AI data scientist to aid in…
Certara2023 年 2 月 3 日
Machine learning model selection with Darwin in Pirana
探索如何通过 Pirana Darwin 模块优化机器学习模型筛选。Watch this on-demand…
Certara2023 年 2 月 3 日
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
PRINCETON, N.J.— 2023 年 2 月 1 日-- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today…
Certara2023 年 2 月 1 日
How Modeling & Simulation is Addressing the Immunogenicity Challenge: An academic nicety is now a drug development and regulatory differentiator
Learn how modeling and simulation can help drug developers overcome the immunogenicity challenge, a major…
Certara2023 年 1 月 30 日
